Source:http://linkedlifedata.com/resource/pubmed/id/16394469
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2006-1-5
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0378-6323
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
363-4
|
pubmed:meshHeading |
pubmed-meshheading:16394469-Albendazole,
pubmed-meshheading:16394469-Antiparasitic Agents,
pubmed-meshheading:16394469-Causality,
pubmed-meshheading:16394469-Endemic Diseases,
pubmed-meshheading:16394469-Humans,
pubmed-meshheading:16394469-Immunocompromised Host,
pubmed-meshheading:16394469-Immunosuppression,
pubmed-meshheading:16394469-Ivermectin,
pubmed-meshheading:16394469-Strongyloidiasis,
pubmed-meshheading:16394469-Tropical Climate
|
pubmed:articleTitle |
Preventing strongyloidiasis in the immunosuppressed.
|
pubmed:publicationType |
Letter,
Comment
|